Neuromuscular diseases associated with chronic hepatitis C virus infection

Journal of Clinical Neuromuscular Disease

Volumn 13, Issue 1, 2011, Pages 14-25

  Stübgen, Joerg Patrick ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

HCV; hepatitis C virus; myasthenia gravis; myopathy; neuropathy

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; AUTOANTIBODY; AZATHIOPRINE; BETA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; JO 1 ANTIBODY; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; PREDNISONE; RECOMBINANT ALPHA INTERFERON; RHEUMATOID FACTOR; RITUXIMAB; STEROID; VIRUS RNA;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL PROLIFERATION; CRANIAL NEUROPATHY; CRYOGLOBULINEMIA; DERMATOMYOSITIS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCLUSION BODY MYOSITIS; MYASTHENIA GRAVIS; MYOPATHY; NEUROMUSCULAR DISEASE; NEUROPATHY; NONHODGKIN LYMPHOMA; OCULOMOTOR NERVE DISEASE; PATHOGENESIS; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYARTERITIS NODOSA; POLYMYOSITIS; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T LYMPHOCYTE; TH2 CELL; THYMECTOMY; TREATMENT RESPONSE; VASCULITIS;

AUTOIMMUNE DISEASES; COMORBIDITY; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MUSCULAR DISEASES; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 80052506302     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3181d4a527     Document Type: Review

References (107)

1. Liang TJ, Rehermann B, Seeff LB, et al. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 2000;132:296-305 (Pubitemid 30106261)
2. Lauer GM, Walker GM. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52 (Pubitemid 32634271)
3. Agnello V, DeRosa F. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol. 2004;40:341-352 (Pubitemid 38115844)
4. Séne D, Limal N, Cacoub P. Hepatitis C virusassociated extrahepatic manifestations: a review. Metab Brain Dis. 2004;19:357-381 (Pubitemid 39361194)
5. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis. 2008;3:25-41
6. Levey JM, Bjornsson B, Banner B, et al. Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature. Medicine. 1994;73:53-67
7. Wong VS, Egner W, Elsey T, et al. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol. 1996;104:25-31 (Pubitemid 26103408)
8. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42:2204-2212 (Pubitemid 30263607)
9. Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol. 2005;17:447-455 (Pubitemid 41058405)
10. Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613-619
11. Czaja AJ. Extrahepatic immunological features of chronic viral hepatitis. Dig Dis Sci. 1997;15: 125-144 (Pubitemid 127523164)
12. Valentini G, Mantelli A, Persico M, et al. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions. Clin Exp Rheumatol. 1999;17:75-79 (Pubitemid 29099891)
13. Eng MA, Kallemuchikkal U, Gorevic PD. Hepatitis C virus, autoimmunity and lymphoproliferation. Mt Sinai J Med. 2000;67:120-132 (Pubitemid 30152344)
14. McMurray R. Hepatitis C-associated autoimmune disorders. Rheum Dis Clin North Am. 1998;24: 353-374 (Pubitemid 28256643)
15. Bianchi FB, Muratori P, Granito A, et al. Hepatitis C and autoreactivity. Dig Liver Dis. 2007;39(Suppl 1): S22-S24 (Pubitemid 47541921)
16. Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep. 2006; 8:53-59
17. Santoro L, Manganelli F, Briani C, et al. Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population. J Neurol Neurosurg Psychiatry. 2006;77:626-629 (Pubitemid 43844587)
18. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC Groupe dEtude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de lHepatite C. Medicine. 2000;79:47-56 (Pubitemid 30077736)
19. Téllez-Zenteno JF, Calva-Mercado J, Weder-Cisneros N, et al. Prevalence and risk factors associated with the presence of peripheral neuropathy in patients with hepatitis C virus infection. J Clin Neuromusc Dis. 2003;4:109-114 (Pubitemid 38404417)
20. Zaltron S, Puoti M, Liberini P, et al. High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinemia. Ital J Gastroenterol Hepatol. 1998;30:391-395 (Pubitemid 28445782)
21. Gomes I, Nora DB, Marquezini NC, et al. Peripheral neuropathy in patients with hepatitis virus C infection in the Amazon region. Arq Neuropsiquiatr. 2006;64:600-602
22. Apartis E, Léger JM, Musset L, et al. Peripheral neuropathy associated with essential cryoglobulinemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry. 1996;60:661-666
23. Authier FJ, Pawlotsky JM, Viard JP, et al. High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy. Ann Neurol. 1993;34:749-750
24. Garcia-Bragado F, Fernandez JM, Navarro C, et al. Peripheral neuropathy in essential mixed cryoglobulinemia. Arch Neurol. 1988;45:1210-1214
25. Gemignani F, Pavesi G, Fiocchi A, et al. Peripheral neuropathy in essential mixed cryoglobulinemia. J Neurol Neurosurg Psychiatry. 1992;55:116-120
26. Nemni R, Sanvito L, Quattrini A, et al. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinemia. J Neurol Neurosurg Psychiatry. 2003;74:1267-1271
27. De Martino L, Sampaola S, Tucci C, et al. Viral RNA in nerve tissue of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve. 2003;27: 102-104 (Pubitemid 36083451)
28. Lidove O, Cacoub P, Maisonobe T, et al. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinemia. Ann Rheum Dis. 2001;60:290-292 (Pubitemid 32260617)
29. Lidove O, Maisonobe T, Servan J, et al. Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia. Rev Med Interne. 2001;22: 939-947 (Pubitemid 32979342)
30. Paoletti V, Donnarumma L, De Matteis A, et al. Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection. Panminerva Med. 2000;42:175-178
31. Rafai MA, Gam I, Fadel H, et al. The presentation of viral hepatitis C infection without cryoglobulinemia with peripheral neuropathy. Five case reports. Rev Neurol. 2006;162:623-627
32. Authier FJ, Bassez G, Payan C, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology. 2003; 60:808-812 (Pubitemid 36297365)
33. David WS, Peine C, Schlesinger P, et al. Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C. Muscle Nerve. 1996;19:1596-1602 (Pubitemid 26412116)
34. Ijichi T, Kono I, Mori S, et al. Peripheral neuropathy in Japanese patients with hepatitis C virus infection. Intern Med. 2003;42:377-378
35. Tembl JI, Ferrer JM, Sevilla MT, et al. Neurologic complications associated with hepatitis C virus infection. Neurology. 1999;53:861-864 (Pubitemid 29448315)
36. Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol. 2001;28:109-118 (Pubitemid 32062032)
37. Lacaille F, Zylberberg H, Hagege H, et al. Hepatitis C associated with Guillain-Barré syndrome. Liver. 1998;18:49-51
38. Suzuki H, Takei T, Tsuji H, et al. Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II cryoglobulinemia associated with HCV infection. Intern Med. 2000; 39:397-400
39. Costa J, Resende C, de Carvalho M. Motor-axonal neuropathy associated with hepatitis C virus. Eur J Neurol. 2003;10:183-185 (Pubitemid 36308214)
40. Bonetti B, Invernizzi F, Rizzuto N, et al. T-cellmediated epineural vasculitis and humeral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol. 1997;73:145-154 (Pubitemid 27105280)
41. Migliaresi S, Di Iorio G, Ammendola A, et al. Peripheral nervous system involvement in HCVrelated mixed cryoglobulinemia. Reumatismo. 2001;53:26-32
42. Bonetti B, Scardoni M, Monaco S, et al. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinemia. Virchows Arch. 1999;434: 533-535 (Pubitemid 29281312)
43. Chad D, Pariser K, Bradley WG, et al. The pathogenesis of cryoglobulinemic neuropathy. Neurology. 1982;32:725-729 (Pubitemid 12078050)
44. Thomas FP, Lovelace RE, Ding XS, et al. Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IgM monoclonal gammopathy. Muscle Nerve. 1992;15:891-898
45. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490-1495
46. Poynard T, Marcellin P, Lee SS, et al. Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet. 1998;352:1426-1432 (Pubitemid 28510876)
47. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis International Therapy Group. N Engl J Med. 1998;339:1485-1492 (Pubitemid 28543496)
48. Cacoub P, Lidove O, Maisonobe T, et al. Interferonalpha and ribavirin treatment in patients with hepatitis C-related systemic vasculitis. Arthritis Rheum. 2002;46:3317-3326 (Pubitemid 35453543)
49. Ammendola A, Sampaolo S, Ambrosone L, et al. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. Muscle Nerve. 2005;31:382-385 (Pubitemid 40261412)
50. Ferri C, Marzo E, Longombardo G, et al. Interferonalpha in mixed cryoglobulinemia patients: randomized, crossover-controlled trial. Blood. 1993;81: 1132-1136 (Pubitemid 23067346)
51. Naarendorp M, Kallemuchikkal U, Nuovo GJ, et al. Longterm efficacy of interferon-alpha for extrahepatic disease with hepatitis C infection. J Rheumatol. 2001;28:2466-2473 (Pubitemid 33031978)
52. Mazzaro C, Zorat F, Caizzi M, et al. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol. 2005;42:632-638
53. Cacoub P, Saadoun D, Limal N, et al. Pegylated interferon alpha-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2005;52:911-915 (Pubitemid 40365115)
54. Saadoun D, Resche-Rigon M, Thibault V, et al. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis. Arthritis Rheum. 2006;54:3696-3706 (Pubitemid 44737183)
55. Sansonno D, De Re V, Lauletta G, et al. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferona with an anti-CD20. Blood. 2003;101:3818-3826 (Pubitemid 36857852)
56. Zaja F, De Vita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003;101:3827-3834 (Pubitemid 36857853)
57. Cai FZ, Ahern M, Smith M. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol. 2006;33:1197-1198 (Pubitemid 43825478)
58. Lamprecht P, Lerin-Lozano C, Merz H, et al. Rituximab induces remission in refractory HCV associated cryoglobulinemic vasculitis. Ann Rheum Dis. 2003;62:1230-1233 (Pubitemid 37500635)
59. Halfon P, Levy M, San Marco M, et al. Myasthenia gravis and hepatitis C virus infection. J Viral Hepatol. 1996;3:329-332 (Pubitemid 126734169)
60. Reading PJ, Newman PK. Untreated hepatitis C may provoke myasthenia gravis. J Neurol Neurosurg Psychiatry. 1998;64:820 (Pubitemid 28274427)
61. Eddy S, Wim R, Peter VE, et al. Myasthenia gravis: another autoimmune disease associated withhepatitis C virus infection. Dig Dis Sci. 1999;44:186-189 (Pubitemid 29053097)
62. Buskila D, Shnaider A, Neumann L, et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients. Semin Arthritis Rheum. 1998;28:107-113 (Pubitemid 28480895)
63. Alric L, Partensky J, Reynaud D, et al. Association between polymyositis and hepatitis C infection. Treatment-related difficulties. Rev Med Interne. 2000;21:542-546
64. Nishikai M, Miyairi M, Kosaka S. Dermatomyositis following infection with hepatitis C virus. J Rheumatol. 1994;21:1584-1585 (Pubitemid 24261558)
65. Monger RM, West SG. Inflammatory myopathy and hepatitis C virus infection. Arthritis Rheum. 1998; 41:1323-1324 (Pubitemid 28313438)
66. Ayabe M, Kawamoto M, Ijima H, et al. Clinical characteristics and muscle histopathology in polymyositis positive anti-hepatitis with C virus antibody. Rinsho Shinkeigaku. 1997;37:208-211 (Pubitemid 27294934)
67. Agha B, Rasheed M, Kenyon L, et al. Hepatitis C virus infection, inflammatory myopathy, and pulmonary fibrosis: are they related? J Clin Rheumatol. 2002;8:44-49 (Pubitemid 34155651)
68. Aisa Y, Yokomori H, Kashiwagi K, et al. Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection. Intern Med. 2001;40:1109-1112 (Pubitemid 33133720)
69. Blasini AM, Alonso EJ, Stekman IL, et al. Treatment with alpha-interferon for hepatitis C infection in a patient with polymyositis. J Clin Rheumatol. 1996;2:26-237
70. Ferri C, La Civita L, Fazzi P, et al. Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum. 1996; 39:1074-1075
71. Harada M, Sata M, Yoshida H, et al. Inflammatory myopathy associated with hepatitis C virus infection: a report of 4 cases. Int Hepatol Commun. 1995;4:195-200 (Pubitemid 26004735)
72. Horsmans Y, Geubel AP. Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet. 1995;345:1236
73. Ito H, Ito H, Nagano M, et al. In situ identification of hepatitis C virus RNA in muscle. Neurology. 2005; 64:1073-1075 (Pubitemid 40388468)
74. Kato T, Okai T, Shiroma T, et al. Marked increase in serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis. Clin Rheumatol. 2005;24:182-186 (Pubitemid 40552977)
75. Mercado U, Avendano-Reyes M. Development of myositis after hepatitis C virus infection. Clin Exp Rheumatol. 2005;23:429-430 (Pubitemid 40823561)
76. Mohan P, Chandra RS, Escolar DM, et al. Inflammatory myopathy and hepatitis C in a pediatric patient: role of liver biopsy in evaluating the severity of liver disease. Hepatology. 2001;34: 851-852 (Pubitemid 32928018)
77. Ueno Y, Kondo K, Kidokoro N, et al. Hepatitis C infection and polymyositis. Lancet. 1995;346: 319-320
78. Villanova M, Caudai C, Sabatelli P, et al. Hepatitis C virus infection and myositis: a polymerase chain reaction study. Acta Neuropathol. 2000;99: 271-276 (Pubitemid 30099176)
79. Weidensaul D, Imam T, Holyst MM, et al. Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum. 1995;3:437-439
80. Di Muzio A, Bonetti B, Capasso M, et al. Hepatitis C virus infection and myositis: a virus localization study. Neuromusc Disord. 2003;13:68-71 (Pubitemid 35430142)
81. Fiore G, Giacovazzo F, Giacovazzo M. HCV and dermatomyositis: report of 5 cases of dermatomyositis in patients with HCV infection. Riv Eur Sci Med Farmacol. 1996;18:197-201 (Pubitemid 28086040)
82. Germany RE, Cohen SM. Hepatitis C, collagenous colitis, and dermatomyositis occurring in the same patient. Am J Gastroenterol. 2002;97:1848-1849 (Pubitemid 34761426)
83. Moccia F. Autoimmune thrombocytopenic purpura and dermatomyositis associated with chronic hepatitis C. A therapeutic dilemma. Ann Ital Med Int. 1998;13:240-243 (Pubitemid 29063304)
84. Nakamura K, Matsumori A, Kusano KF, et al. Hepatitis C virus infection in a patient with dermatomyositis and left ventricular dysfunction. Jpn Circ J. 2000;64:617-618
85. Alexander JA, Huebner CJ. Hepatitis C and inclusion body myositis. Am J Gastroenterol. 1996; 91:1845-1847 (Pubitemid 26307196)
86. Kase S, Shiota G, Fujii Y, et al. Inclusion body myositis associated with hepatitis C virus infection. Liver. 2001;21:357-360 (Pubitemid 32910561)
87. Tsuruta Y, Yamada T, Yoshimura T, et al. Inclusion body myositis associated with hepatitis C virus infection. Fukuoka Igaku Zasshi. 2001;92:370-376
88. Yakushiji Y, Satoh J, Yukitake M, et al. Interferon beta-responsive inclusion body myositis in a hepatitis C virus carrier. Neurology. 2004;63:587-588 (Pubitemid 39031404)
89. Satoh J, Eguchi Y, Narukiyo T, et al. Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case report and a review of the literature. Int Med. 2000;39:176-181 (Pubitemid 30187239)
90. Sola P, Galassi G, Merelli E, et al. Detection of HCVspecific sequences in chronic myopathy with hepatitis C: improvement with interferon-alpha 2A therapy. Eur Neurol. 1999;42:181-183 (Pubitemid 29472102)
91. Irving W, Day S, Johnston I. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis. 1993;148:1683-1684 (Pubitemid 24002509)
92. Rull M, Zonay L, Schumacher HR Jr. Hepatitis C and rheumatic diseases. J Muskuloskelet Med. 1998;15: 38-44
93. Gomez A, Solans R, Simeon CP, et al. Dermatomyositis, hepatocellular carcinoma, and hepatitis C: comment on the article by Weidensaul et al. Arthritis Rheum. 1997;40:394-395
94. Inuzuka M, Tomita K, Tokura Y, et al. Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma. Br J Dermatol. 2001;144:416-417 (Pubitemid 32178833)
95. Kee KM, Wang JH, Lee CM, et al. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma. Chang Gung Med J. 2004;27:834-839
96. Toshikuni N, Torigoe R, Mitsunaga M, et al. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis. World J Gastroenterol. 2006;12:1641-1644
97. Cheng TI, Tsou MH, Yang PS, et al. Dermatomyositis and erythrocytosis in a patient with hepatocellular carcinoma. J Gastroenterol Hepatol. 2002; 17:1239-1240
98. Kee SJ, Kim TJ, Lee SJ, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int. 2009;29:595-599
99. Gray RG, Altman RD, Gottlieb NL. Aberrant serum enzyme patterns in dermatomyositis associated with hepatoma. J Rheumatol. 1976;3:227-232
100. Horie Y, Yamada M, Nakai K, et al. Combined hepatocellular- cholangiocarcinoma associated with dermatomyositis. J Gastroenterol Hepatol. 1989;4:101-104 (Pubitemid 19108319)
101. Ferri C, Monti M, La Civita L, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 1993;82: 3701-3704 (Pubitemid 24006053)
102. Ferri C, La Civita L, Longombardo G, et al. Hepatitis C virus and mixed cryoglobulinema. Eur J Clin Invest. 1993;23:399-405
103. Theofilopoulos AN, Baccala R, Beutler B, et al. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005;23:307-336 (Pubitemid 40563172)
104. Mathews MB, Bernstein RM. Myositis autoantibody inhibiting histidyl-tRNA synthetase: a model for autoimmunity. Nature. 1983;304:177-179 (Pubitemid 13079148)
105. Zhu N, Khoshnan A, Schneider R, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1and enhances TNF-induced apoptosis. J Virol. 1998; 72:3691-3697 (Pubitemid 28188666)
106. Shiota G, Okano J, Kawasaki H, et al. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology. 1995;21: 106-112
107. Allen RE, Sheehan SM, et al. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J Cell Physiol. 1995;165:307-312